# ProSolus doubles transdermal patch capacity with new Texas facility

ProSolus Pharmaceuticals, owned by Mission Pharmacal, opened a new transdermal patch manufacturing facility in Boerne, Texas, more than doubling its capacity to up to 100 million patches per year. The company already has a facility in Miami, Florida.

- Type: Expansion
- Announced: 2017-05-04
- Where: Boerne, Texas, United States
- Starts operating: 4 May 2017
- Status: completed
- Capacity: 100 million patches per year
- Products: transdermal patches
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ProSolus Pharmaceuticals](https://endata.com/companies/24053.md)
- [Mission Pharmacal](https://endata.com/companies/23889.md) (partner)

## Sources

- [fiercepharma.com](https://www.fiercepharma.com/manufacturing/transdermal-patch-manufacturer-prosolus-doubles-capacity-texas-facility), 2017-05-04: "ProSolus, which already has a transdermal patch manufacturing facility in Florida, has opened a larger plant in Texas."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.